National Healthcare Stock (AMEX:NHC), Trade Ideas

National Healthcare

National Healthcare Corp Provides long-term care facilities. Its principal business includes the operation of skilled nursing facilities, assisted living facilities, independent living facilities, and home care programs. The company's activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, and home health care services. In addition, the company also provides management services, accounting, and financial services, as well as insurance services to third-party operators of healthcare facilities. Its reportable segments include Inpatient services, and Home care hospice services. Generating, a majority of its revenue from Inpatient services.

News

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

BMEA

BYND

CCSI

CLSK

COIN

CVGW

CVNA

FLNC

IDXX

MARA

MSTR

NEGG

RILY

RIOT

SAIC

SPOT

TERN

UBER

WULF

U.S. stocks traded lower, with the Dow Jones index falling more than 100 points on Monday.

SAIC Reports Q3 Results, Joins Uber, Wallbox And Other Big Stocks Moving Higher On Monday

Short Ideas

Pre-Market Outlook

CAPR

PRAX

REGN

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Top 5 Health Care Stocks That May Fall Off A Cliff

Long Ideas

Insider Trades

BDTX

HCSG

Although US stocks closed slightly higher on Monday, there were a few notable insider trades.

$5M Bet On This Biotechnology Stock? Check Out These 3 Stocks Insiders Are Buying

National HealthCare Corporation Common Stock

National Healthcare Corp

NHC COMMUNS INC by NHC Communications Inc.

NIHON CHOUZAI CO LTD ORD by Nihon Chouzai Co., Ltd.

Nihon Chouzai Co Ltd

National Healthcare (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/NHC#AMEX">NHC</a>) reported quarterly earnings of $1.03 per share. This is a 43.06 percent increase over earnings of $0.72 per share from the same period last year. The company reported $300.91 million in sales this quarter. This is a 13.74 percent increase over sales of $264.55 million the same period last year.

Earnings

National Healthcare Q4 Adj. EPS $1.03 Up From $0.72 YoY, Sales $300.91M Up From $264.55M YoY

U.S. stocks traded lower, with the Dow Jones index falling more than 100 points on Monday.
Shares of Science Applications International Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/saic#NYSE">SAIC</a>) surged during Monday&rsquo;s session after the company reported third-quarter financial results and raised FY24 <a href="https://www.benzinga.com/news/earnings/23/12/36066719/why-it-company-saics-shares-are-surging-today">guidance above estimates</a>.
SAIC reported a 1% revenue decline Y/Y in Q3 FY24 to $1.895 billion, beating the consensus of $1.790 billion. Adjusted EPS of $2.27 beat the consensus of $1.69.
SAIC raised revenue guidance to $7.325 billion - $7.350 billion (prior $7.20 billion - $7.25 billion). The company increased adjusted EPS guidance to $7.70 - $7.90 (prior $7.20 - $7.40).
Science Applications International shares rose 6.9% to $128.20 on Monday.
Here are some other big stocks recording gains in today&rsquo;s session.
<ul>
<li>Hawaiian Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ha#NASDAQ">HA</a>) shares jumped 187% to $14.03 after Alaska Air Group, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/alk#NYSE">ALK</a>) announced plans to acquire the company in a deal worth $1.9 billion.</li>
<li>XBP Europe Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xbp#NASDAQ">XBP</a>) rose 39.5% to $33.28.</li>
<li>Beyond Meat, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bynd#NASDAQ">BYND</a>) shares gained 23.6% to $9.36.</li>
<li>B. Riley Financial, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rily#NASDAQ">RILY</a>) jumped 19.4% to $24.09. Bryant R. Riley reported sale of most of its stake in Arena Group to Arena.</li>
<li>Biomea Fusion, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bmea#NASDAQ">BMEA</a>) climbed 18.8% to $19.82.</li>
<li>Wallbox N.V. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wbx#NYSE">WBX</a>) gained 16.3% to $1.8150 after Generac announced it made a minority investment in the company.</li>
<li>CleanSpark, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clsk#NASDAQ">CLSK</a>) surged 16.1% to $8.87amid a weekend increase in the price of Bitcoin.</li>
<li>Newegg Commerce, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/negg#NASDAQ">NEGG</a>) shares rose 15.5% to $2.08.</li>
<li>Carvana Co. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cvna#NYSE">CVNA</a>) rose 15.3% to $40.56 after JP Morgan upgraded the stock from Underweight to Neutral and raised its price target from $25 to $40.</li>
<li>Terns Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tern#NASDAQ">TERN</a>) surged 15.3% to $6.02.</li>
<li>Consensus Cloud Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ccsi#NASDAQ">CCSI</a>) rose 12.6% to $21.55.</li>
<li>TeraWulf Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wulf#NASDAQ">WULF</a>) gained 12.5% to $1.54 amid a weekend surge in the price of Bitcoin.</li>
<li>Calavo Growers, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cvgw#NASDAQ">CVGW</a>) jumped 11.9% to $25.67.</li>
<li>Marathon Digital Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mara#NASDAQ">MARA</a>) surged 11.4% to $15.26 amid a weekend surge in the price of Bitcoin.</li>
<li>Riot Platforms, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/riot#NASDAQ">RIOT</a>) gained 11.1% to $15.30 amid a weekend surge in the price of Bitcoin.</li>
<li>National HealthCare Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nhc#NYSE">NHC</a>) rose 10.3% to $85.56.</li>
<li>Spotify Technology S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/spot#NYSE">SPOT</a>) climbed 8.6% to $196.07. Spotify CEO Daniel Ek announced significant organizational changes, including reducing the company&#39;s headcount by approximately 17%.</li>
<li>Fluence Energy, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/flnc#NASDAQ">FLNC</a>) gained 7% to $27.57. Roth MKM upgraded Fluence Energy from Neutral to Buy and raised the price target from $27 to $31.</li>
<li>IDEXX Laboratories, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/idxx#NASDAQ">IDXX</a>) gained 6.4% to $513.47.</li>
<li>GameStop Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gme#NYSE">GME</a>) climbed 6% to $16.19.</li>
<li>MicroStrategy Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mstr#NASDAQ">MSTR</a>) rose 6% to $558.56 amid a weekend surge in the price of Bitcoin.</li>
<li>Coinbase Global, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/coin#NASDAQ">COIN</a>) gained 5.5% to $141.14 amid a weekend surge in the price of Bitcoin.</li>
<li>Uber Technologies, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/uber#NYSE">UBER</a>) climbed 5% to $60.22 after an announcement that the company would join the S&amp;P 500 index.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/23/12/36069416/over-2m-bet-on-this-industrial-stock-check-out-these-4-penny-stocks-insiders-are-aggress"> Over $2M Bet On This Industrial Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying</a>

Robert G Adams, Board Member at National Healthcare (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/NHC#AMEX">NHC</a>), reported a large insider buy on September 14, according to a new SEC filing. 
What Happened: A Form 4 filing from the <a href="https://www.sec.gov/Archives/edgar/data/0001047335/000143774923025905//Archives/edgar/data/1047335/000143774923025905/0001437749-23-025905-index.htm">U.S. Securities and Exchange Commission</a> on Thursday showed that Adams purchased 2,000 shares of National Healthcare. The total transaction amounted to $133,923. 
National Healthcare shares are trading down 0.77% at $67.32 at the time of this writing on Friday morning.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Why Insider Transactions Are Important</h3>
Insider transactions shouldn't be used primarily to make an investing decision, however, they can be an important factor for an investor to consider.
In legal terms, an "insider" refers to any shareholder who owns at least 10% of a company. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.
When a company insider makes a new purchase, that is an indication that they expect the stock to rise.
Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down. 
<h3>Important Transaction Codes</h3>
<a href="https://www.benzinga.com/money/investing-tools">Investors</a> prefer focusing on transactions that take place in the open market, indicated in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S indicates a sale. Transaction code C indicates the conversion of an option, and transaction code A indicates the insider may have been forced to sell shares in order to receive compensation that had been promised upon being hired by the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001047335">Check Out The Full List Of National Healthcare's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

National Healthcare Board Member Trades $133K In Company Stock

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
The RSI is a momentum indicator, which compares a stock&#39;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#39;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi"> RSI is above 70.</a>
Here&rsquo;s the latest list of major overbought players in this sector.
<h3>Capricor Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/capr#NASDAQ">CAPR</a>)</h3>
<ul>
<li>The company posted better-than-expected quarterly results. &ldquo;In the second quarter of 2023 we presented positive two-year data from our ongoing HOPE-2 open label extension (OLE) study, which we believe further supports our rapidly advancing late-stage clinical development program for CAP-1002 in patients with Duchenne Muscular Dystrophy (DMD),&rdquo; said Linda Marb&aacute;n, Ph.D., Capricor&rsquo;s chief executive officer. The company&rsquo;s stock has a <a href="https://www.benzinga.com/quote/CAPR">52-week high of $8.11. </a>.</li>
<li>RSI Value: 71.52</li>
<li>CAPR Price Action: Shares of Capricor Therapeutics fell 4.9% to close at $7.34 on Monday.</li>
</ul>
<h3>Praxis Precision Medicines, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prax#NASDAQ">PRAX</a>)</h3>
<ul>
<li>Praxis Precision Medicine posted a narrower second-quarter loss. &ldquo;Our four clinical-stage programs continue to make great progress, and we are excited to be advancing ulixacaltamide into Phase 3,&rdquo; said Marcio Souza, president and chief executive officer of Praxis. The company&rsquo;s <a href="https://www.benzinga.com/quote/PRAX"> stock has a 52-week high </a> of $5.25.</li>
<li>RSI Value: 71.29</li>
<li>PRAX Price Action: Shares of Praxis Precision Medicines fell 3.5% to close at $1.40 on Tuesday.</li>
</ul>
<h3>National HealthCare Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nhc#NYSE">NHC</a>)</h3>
<ul>
<li>For the quarter ended June 30, 2023, the reported GAAP net income attributable to NHC was $16,281,000, up from $3,203,000 for the year-ago period. The company has a <a href="https://www.benzinga.com/quote/NHC"> 52-week high </a> of $70.78.</li>
<li>RSI Value: 74.30</li>
<li>NHC Price Action: Shares of National HealthCare fell 0.7% to close at $68.56 on Tuesday.</li>
</ul>
<h3>Regeneron Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/regn#NASDAQ">REGN</a>)</h3>
<ul>
<li>Regeneron Pharmaceuticals Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/regn#NASDAQ">REGN</a>) was awarded a government contract valued at up to $326 million. &quot;Although COVID-19 has moved to an endemic stage, many people &ndash; including those with immunocompromising conditions &ndash; continue to face exposure that impacts their everyday life and could cause serious health consequences,&quot; said Leonard Schleifer, board co-chair, president and CEO of Regeneron. The company&rsquo;s 52-week high is $10.25.</li>
<li>RSI Value: 76.55</li>
<li>REGN Price Action: Shares of Regeneron Pharmaceuticals fell 0.4% to close at $840.63 on Monday.</li>
</ul>
<h3>Dr. Reddy&#39;s Laboratories Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rdy#NYSE">RDY</a>)</h3>
<ul>
<li>Dr Reddy&#39;s Laboratories reported better-than-expected first-quarter financial results. Co-Chairman &amp; MD, G V Prasad said, &quot;We delivered strong sales growth and witnessed robust margin expansion in Q1FY24 driven by market share gains &amp; new product momentum in our US generics business and superior performance in Russia.&quot; The company <a href="https://www.benzinga.com/quote/RDY"> has a 52-week high </a> of $72.13.</li>
<li>RSI Value: 75.61</li>
<li>RDY Price Action: Shares of Dr. Reddy&#39;s Laboratories fell 0.4% to settle at $71.47 on Tuesday.</li>
</ul>
&nbsp;
Read More: <a href="https://www.benzinga.com/news/earnings/23/08/33998119/advance-auto-parts-likely-to-post-sharp-decline-in-q2-earnings-heres-a-look-at-recent-price-target-"> Advance Auto Parts Likely To Post Sharp Decline In Q2 Earnings; Here&#39;s A Look At Recent Price Target Changes By The Most Accurate Analysts</a>

Although US stocks closed slightly higher on Monday, there were a few notable insider trades.
When insiders purchase shares, it indicates their confidence in the company&#39;s prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.
Below is a look at a few recent notable insider purchases. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/"> Benzinga&#39;s insider transactions </a> platform.
<h3>Black Diamond Therapeutics </h3>
<ul>
<li>The Trade: Black Diamond Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bdtx#NASDAQ">BDTX</a>) 10% owner BB Biotech AG <a href="https://www.benzinga.com/quote/BDTX/analyst-ratings"> acquired a total of 1,000,000 shares </a> an average price of $5.00. To acquire these shares, it cost around $5 million.</li>
<li>What&rsquo;s Happening: Stifel upgraded Black Diamond Therapeutics from Hold to Buy and raised the price target from $2 to $10.</li>
<li>What Black Diamond Therapeutics Does: Black Diamond Therapeutics Inc is a precision oncology medicine company.</li>
</ul>
<h3>National HealthCare </h3>
<ul>
<li>The Trade: National HealthCare Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nhc#NYSE">NHC</a>) Director Richard F. Laroche Jr. acquired a total of 2,100 shares at an average price of $61.40. To acquire these shares, it cost around $128,944.</li>
<li>What&rsquo;s Happening: - -National HealthCare reported net operating revenues and grant income for the quarter ended March 31, 2023 totaled $269,563,000, up from $278,983,000 for the quarter ended March 31, 2022.</li>
<li>What National HealthCare Does: National Healthcare Corp Provides long-term care facilities. Its principal business includes the operation of skilled nursing facilities, assisted living facilities, independent living facilities, and home care programs.</li>
</ul>
Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a> 
<h3>Healthcare Services Group </h3>
<ul>
<li>The Trade: Healthcare Services Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hcsg#NASDAQ">HCSG</a>) Director Kurt Simmons Jr <a href="https://www.benzinga.com/sec/insider-trades/"> bought a total of 1,005 shares </a> at an average price of $14.93. To acquire these shares, it cost around $15,005.</li>
<li>What&rsquo;s Happening: Healthcare Services Group reported revenue of $417.2 million for the three months ended March 31, 2023.</li>
<li>What Healthcare Services Group Does: Healthcare Services Group Inc is a provider of housekeeping and facility management services to the healthcare industry.</li>
</ul>
&nbsp;
Check This Out: <a href="https://www.benzinga.com/news/earnings/23/07/33111009/investor-sentiment-declines-ahead-of-fed-minutes"> Investor Sentiment Declines Ahead Of Fed Minutes </a>

Ernest G. Burgess III, Board Member at National Healthcare (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/NHC#AMEX">NHC</a>), reported a large insider buy on May 17, according to a new SEC filing. 
What Happened: A Form 4 filing from the <a href="https://www.sec.gov/Archives/edgar/data/0001047335/000143774923014974//Archives/edgar/data/1047335/000143774923014974/0001437749-23-014974-index.htm">U.S. Securities and Exchange Commission</a> on Wednesday showed that III purchased 2,300 shares of National Healthcare. The total transaction amounted to $135,350. 
National Healthcare shares are trading up 1.33% at $59.46 at the time of this writing on Thursday morning.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>The Importance of Insider Transactions</h3>
Insider transactions shouldn't be used primarily to make an investing decision, however, they can be an important factor for an investor to consider.
In legal terms, an "insider" refers to any shareholder who owns at least 10% of a company. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.
When a company insider makes a new purchase, that is an indication that they expect the stock to rise.
Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down. 
<h3>Important Transaction Codes</h3>
<a href="https://www.benzinga.com/money/investing-tools">Investors</a> prefer focusing on transactions that take place in the open market, indicated in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S indicates a sale. Transaction code C indicates the conversion of an option, and transaction code A indicates the insider may have been forced to sell shares in order to receive compensation that had been promised upon being hired by the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001047335">Check Out The Full List Of National Healthcare's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Board Member At This Health Care Company Buys $135K of Stock

<h1>&nbsp;</h1>
On Monday, 36 companies set new 52-week lows.
<h2>Noteworthy Mentions In Today&#39;s 52-Week Lows:</h2>
<ul>
<li>The largest company by market cap to hit a new 52-week low was Sirius XM Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIRI#NASDAQ">SIRI</a>).</li>
<li>The smallest company by market cap to set a new 52-week low was Altamira Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYTO#NASDAQ">CYTO</a>).</li>
<li>China Pharma Holding (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CPHI#AMEX">CPHI</a>) saw the most significant move of the companies, as shares traded down 871.52% to reach its new 52-week low.</li>
<li>VEON (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VEON#NASDAQ">VEON</a>) shares rebounded the highest, with shares trading up 0.0%, bouncing back after reaching its new 52-week low.</li>
</ul>
Stocks dropping to new 52-week lows on Monday:
<ul>
<li>Sirius XM Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIRI#NASDAQ">SIRI</a>) shares fell to $4.20 on Monday, setting a new 52-week low with a shift of down 0.35%.</li>
<li>Centrais Eletricas (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EBR#NYSE">EBR</a>) shares hit a yearly low of $6.26. The stock was down 1.1% on the session.</li>
<li>Cosan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CSAN#NYSE">CSAN</a>) stock achieved a new 52-week low on Monday morning, hitting $11.14 and moving up 0.09%.</li>
<li>Equity Commonwealth (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQC#NYSE">EQC</a>) shares were down 0.12% for the day, having made a 52-week low of $20.53.</li>
<li>VEON (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VEON#NASDAQ">VEON</a>) stock broke to a new 52-week low of $0.68 on Monday. Shares of the company traded 0.0% (flat).</li>
<li>National Healthcare (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/NHC#AMEX">NHC</a>) shares hit a yearly low of $54.76. The stock was up 0.16% on the session.</li>
<li>Aclaris Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACRS#NASDAQ">ACRS</a>) stock hit a yearly low of $5.77. The stock was down 52.03% for the day.</li>
<li>Greystone Housing Impact (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GHI#NYSE">GHI</a>) shares reached a new 52-week low of $17.05 on Monday morning, moving down 2.4%.</li>
<li>Guaranty Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNTY#NASDAQ">GNTY</a>) shares set a new 52-week low of $30.51. The stock traded down 0.88%.</li>
<li>Surmodics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRDX#NASDAQ">SRDX</a>) shares set a new 52-week low of $19.77. The stock traded down 4.73%.</li>
<li>Bright Health Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BHG#NYSE">BHG</a>) shares reached a new 52-week low of $0.43 on Monday morning, moving down 0.04%.</li>
<li>Amneal Pharmaceuticals (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMRX#NYSE">AMRX</a>) shares moved down 3.65% on Monday to hit a new 52-week low of $1.81, drifting down 3.65%.</li>
<li>enCore Energy (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/EU#AMEX">EU</a>) shares fell to $2.20 on Monday, setting a new 52-week low with a shift of down 1.32%.</li>
<li>Franklin Street Props (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/FSP#AMEX">FSP</a>) stock hit $2.19 on Monday morning, setting a new 52-week low for a change of down 3.31%.</li>
<li>Kinnate Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KNTE#NASDAQ">KNTE</a>) shares were down 4.7% for the day, having made a 52-week low of $4.71.</li>
<li>Aadi Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AADI#NASDAQ">AADI</a>) stock achieved a new 52-week low on Monday morning, hitting $8.89 and moving down 3.97%.</li>
<li>Azure Power Global (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZRE#NYSE">AZRE</a>) shares were down 12.46% for the day, having made a 52-week low of $2.66.</li>
<li>Universal Electronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UEIC#NASDAQ">UEIC</a>) stock drifted down 2.51% on Monday morning to hit a new 52-week low of $11.53.</li>
<li>Cepton (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPTN#NASDAQ">CPTN</a>) shares set a new 52-week low of $0.86. The stock traded down 7.63%.</li>
<li>Intercure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INCR#NASDAQ">INCR</a>) shares were down 6.32% for the day, having made a 52-week low of $2.37.</li>
<li>Solid Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLDB#NASDAQ">SLDB</a>) shares reached a new 52-week low of $5.14 on Monday morning, moving down 1.7%.</li>
<li>AERWINS Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AWIN#NASDAQ">AWIN</a>) stock set a new 52-week low of $1.00 on Monday, moving down 12.5%.</li>
<li>Evaxion Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVAX#NASDAQ">EVAX</a>) stock broke to a new 52-week low of $1.18 on Monday. Shares of the company traded down 6.79%.</li>
<li>China Pharma Holding (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CPHI#AMEX">CPHI</a>) shares hit a yearly low of $0.57. The stock was up 871.52% on the session.</li>
<li>CN Energy Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNEY#NASDAQ">CNEY</a>) shares reached a new 52-week low of $0.28 on Monday morning, moving down 1.99%.</li>
<li>Inpixon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INPX#NASDAQ">INPX</a>) stock hit a yearly low of $0.81. The stock was down 7.34% for the day.</li>
<li>Jupiter Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JUPW#NASDAQ">JUPW</a>) stock hit a yearly low of $0.41. The stock was down 1.7% for the day.</li>
<li>Aptorum Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APM#NASDAQ">APM</a>) stock dropped to a yearly low on Monday of $3.08. Shares traded down 12.25%.</li>
<li>Rubius Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RUBY#NASDAQ">RUBY</a>) stock set a new 52-week low of $0.09 on Monday, moving down 22.26%.</li>
<li>Panbela Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBLA#NASDAQ">PBLA</a>) shares made a new 52-week low of $0.89 on Monday. The stock was down 2.42% for the day.</li>
<li>Petros Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTPI#NASDAQ">PTPI</a>) stock broke to a new 52-week low of $1.71 on Monday. Shares of the company traded up 3.26%.</li>
<li>Kalera (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KAL#NASDAQ">KAL</a>) shares reached a new 52-week low of $4.10 on Monday morning, moving down 2.79%.</li>
<li>Altamira Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYTO#NASDAQ">CYTO</a>) shares hit a yearly low of $2.03. The stock was down 13.11% on the session.</li>
</ul>
Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. <a href="https://pro.benzinga.com/?afmc=2a&amp;utm_source=benzinga.com&amp;utm_medium=web&amp;utm_campaign=premium_products">Click here to learn more</a>.

Options

AADI

ACRS

AMRX

AWIN

AZRE

CNEY

CPHI

CPTN

CSAN

CYTO

EVAX

GNTY

INCR

INPX

JUPW

KNTE

PBLA

PTPI

RUBY

SIRI

SLDB

SRDX

UEIC

VEON

Stocks That Hit 52-Week Lows On Monday

National Healthcare (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/NHC#AMEX">NHC</a>) reported quarterly earnings of $0.72 per share. This is a 29.41 percent decrease over earnings of $1.02 per share from the same period last year. The company reported $264.55 million in sales this quarter. This is a 6.66 percent decrease over sales of $283.43 million the same period last year.

National Healthcare Q4 Adj EPS $0.72 Down From $1.02 YoY, Sales $264.55M Down From $283.43M YoY

<h1>&nbsp;</h1>
On Thursday, 63 companies set new 52-week lows.
<h2>Points of Interest From Today&#39;s 52-Week Lows:</h2>
<ul>
<li>Palo Alto Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PANW#NASDAQ">PANW</a>) was the largest company by market cap to set a new 52-week low.</li>
<li>The company with the smallest market cap to set a new 52-week low was Novo Integrated Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVOS#NASDAQ">NVOS</a>).</li>
<li>Silvergate Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SI#NYSE">SI</a>) was the biggest loser of the morning session, as it dropped 45.88% to reach its new 52-week low.</li>
<li>Crescent Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRGY#NYSE">CRGY</a>) shares were the most resilient, as shares rose 0.0%, rebounding from its new 52-week low.</li>
</ul>
On Thursday, the following stocks set new 52-week lows:
<ul>
<li>Palo Alto Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PANW#NASDAQ">PANW</a>) shares were down 2.69% for the day, having made a 52-week low of $133.69.</li>
<li>TC Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRP#NYSE">TRP</a>) stock set a new 52-week low of $38.58 on Thursday, moving down 1.26%.</li>
<li>CrowdStrike Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) shares moved down 8.03% on Thursday to hit a new 52-week low of $94.63, drifting down 8.03%.</li>
<li>Equity Residential (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQR#NYSE">EQR</a>) shares reached a new 52-week low of $57.76 on Thursday morning, moving down 2.51%.</li>
<li>Datadog (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DDOG#NASDAQ">DDOG</a>) stock hit a yearly low of $65.46. The stock was down 3.61% for the day.</li>
<li>Extra Space Storage (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EXR#NYSE">EXR</a>) shares were down 1.88% for the day, having made a 52-week low of $140.65.</li>
<li>Invitation Homes (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INVH#NYSE">INVH</a>) stock hit a new 52-week low of $28.73. The stock was down 2.49% on the session.</li>
<li>Zscaler (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZS#NASDAQ">ZS</a>) shares made a new 52-week low of $105.67 on Thursday. The stock was down 4.13% for the day.</li>
<li>Life Storage (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LSI#NYSE">LSI</a>) stock dropped to a yearly low on Thursday of $94.45. Shares traded down 1.28%.</li>
<li>XP (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XP#NASDAQ">XP</a>) stock broke to a new 52-week low of $13.76 on Thursday. Shares of the company traded down 3.16%.</li>
<li>Signature Bank (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBNY#NASDAQ">SBNY</a>) stock hit $109.95 on Thursday morning, setting a new 52-week low for a change of down 3.02%.</li>
<li>GameStop (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>) shares reached a new 52-week low of $16.41 on Thursday morning, moving down 4.42%.</li>
<li>Teladoc Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDOC#NYSE">TDOC</a>) stock broke to a new 52-week low of $22.32 on Thursday. Shares of the company traded down 2.61%.</li>
<li>Braskem (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAK#NYSE">BAK</a>) stock hit a yearly low of $8.23. The stock was up 0.85% for the day.</li>
<li>Douglas Emmett (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DEI#NYSE">DEI</a>) stock drifted down 2.95% on Thursday morning to hit a new 52-week low of $14.97.</li>
<li>Asana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASAN#NYSE">ASAN</a>) stock hit a yearly low of $12.28. The stock was down 8.02% for the day.</li>
<li>Independent Bank Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBTX#NASDAQ">IBTX</a>) stock drifted down 1.41% on Thursday morning to hit a new 52-week low of $56.37.</li>
<li>Appian (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APPN#NASDAQ">APPN</a>) stock hit $30.55 on Thursday morning, setting a new 52-week low for a change of down 3.01%.</li>
<li>Jamf Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAMF#NASDAQ">JAMF</a>) shares reached a new 52-week low of $18.07 on Thursday morning, moving down 4.96%.</li>
<li>Xenia Hotels &amp; Resorts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XHR#NYSE">XHR</a>) stock dropped to a yearly low on Thursday of $12.48. Shares traded down 0.85%.</li>
<li>Hudson Pacific Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPP#NYSE">HPP</a>) shares hit a yearly low of $9.29. The stock was down 2.58% on the session.</li>
<li>23andMe Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ME#NASDAQ">ME</a>) shares hit a yearly low of $2.03. The stock was down 0.97% on the session.</li>
<li>National Healthcare (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/NHC#AMEX">NHC</a>) shares set a new 52-week low of $56.98. The stock traded down 1.47%.</li>
<li>Allogene Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALLO#NASDAQ">ALLO</a>) shares were down 1.38% for the day, having made a 52-week low of $5.41.</li>
<li>Laredo Petroleum (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LPI#NYSE">LPI</a>) shares made a new 52-week low of $46.62 on Thursday. The stock was up 0.93% for the day.</li>
<li>Simulations Plus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLP#NASDAQ">SLP</a>) stock dropped to a yearly low on Thursday of $33.20. Shares traded down 9.65%.</li>
<li>MultiPlan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPLN#NYSE">MPLN</a>) stock broke to a new 52-week low of $0.98 on Thursday. Shares of the company traded down 4.13%.</li>
<li>First Mid Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FMBH#NASDAQ">FMBH</a>) shares reached a new 52-week low of $31.40 on Thursday morning, moving down 1.72%.</li>
<li>Designer Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DBI#NYSE">DBI</a>) stock hit $9.07 on Thursday morning, setting a new 52-week low for a change of down 1.06%.</li>
<li>CrossFirst Bankshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CFB#NASDAQ">CFB</a>) shares reached a new 52-week low of $11.79 on Thursday morning, moving down 3.86%.</li>
<li>Luther Burbank (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LBC#NASDAQ">LBC</a>) shares moved down 1.19% on Thursday to hit a new 52-week low of $10.72, drifting down 1.19%.</li>
<li>Crescent Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRGY#NYSE">CRGY</a>) shares set a new yearly low of $10.83 this morning. The stock was 0.0% (flat) on the session.</li>
<li>Viad (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VVI#NYSE">VVI</a>) stock hit a new 52-week low of $23.56. The stock was down 2.0% on the session.</li>
<li>Orion Office REIT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ONL#NYSE">ONL</a>) stock hit $8.20 on Thursday morning, setting a new 52-week low for a change of down 0.42%.</li>
<li>Solid Power (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLDP#NASDAQ">SLDP</a>) shares reached a new 52-week low of $2.12 on Thursday morning, moving down 4.24%.</li>
<li>Silvergate Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SI#NYSE">SI</a>) shares reached a new 52-week low of $11.32 on Thursday morning, moving down 45.88%.</li>
<li>Intrepid Potash (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IPI#NYSE">IPI</a>) shares moved up 0.54% on Thursday to hit a new 52-week low of $27.23, drifting up 0.54%.</li>
<li>Seer (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEER#NASDAQ">SEER</a>) shares set a new yearly low of $4.23 this morning. The stock was down 2.41% on the session.</li>
<li>Charge Enterprises (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRGE#NASDAQ">CRGE</a>) shares reached a new 52-week low of $1.11 on Thursday morning, moving down 3.88%.</li>
<li>Bed Bath &amp; Beyond (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BBBY#NASDAQ">BBBY</a>) shares hit a yearly low of $1.83. The stock was down 23.69% on the session.</li>
<li>Lifecore Biomedical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LFCR#NASDAQ">LFCR</a>) stock broke to a new 52-week low of $6.15 on Thursday. Shares of the company traded down 1.72%.</li>
<li>Vera Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERA#NASDAQ">VERA</a>) shares hit a yearly low of $5.50. The stock was down 10.53% on the session.</li>
<li>LL Flooring Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LL#NYSE">LL</a>) shares set a new yearly low of $5.14 this morning. The stock was down 2.4% on the session.</li>
<li>Celularity (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CELU#NASDAQ">CELU</a>) stock hit a yearly low of $1.01. The stock was down 7.36% for the day.</li>
<li>D-Wave Quantum (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QBTS#NYSE">QBTS</a>) shares set a new 52-week low of $1.19. The stock traded down 0.78%.</li>
<li>Xeris Biopharma Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XERS#NASDAQ">XERS</a>) stock drifted down 4.13% on Thursday morning to hit a new 52-week low of $0.97.</li>
<li>Aemetis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMTX#NASDAQ">AMTX</a>) shares fell to $3.70 on Thursday, setting a new 52-week low with a shift of down 3.55%.</li>
<li>Altisource Portfolio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASPS#NASDAQ">ASPS</a>) stock dropped to a yearly low on Thursday of $7.91. Shares traded down 4.62%.</li>
<li>Euroseas (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ESEA#NASDAQ">ESEA</a>) shares fell to $17.65 on Thursday, setting a new 52-week low with a shift of down 1.62%.</li>
<li>Yellow (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YELL#NASDAQ">YELL</a>) shares set a new yearly low of $2.40 this morning. The stock was down 4.55% on the session.</li>
<li>Sono Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEV#NASDAQ">SEV</a>) shares fell to $0.85 on Thursday, setting a new 52-week low with a shift of down 4.84%.</li>
<li>Hydrofarm Holdings Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HYFM#NASDAQ">HYFM</a>) stock broke to a new 52-week low of $1.42 on Thursday. Shares of the company traded down 5.23%.</li>
<li>Ondas Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONDS#NASDAQ">ONDS</a>) stock hit a yearly low of $1.42. The stock was down 4.3% for the day.</li>
<li>RiverNorth Capital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RSF#NYSE">RSF</a>) stock hit a new 52-week low of $16.15. The stock was down 3.07% on the session.</li>
<li>CareCloud (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTBC#NASDAQ">MTBC</a>) stock achieved a new 52-week low on Thursday morning, hitting $2.50 and moving down 3.75%.</li>
<li>Camber Energy (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CEI#AMEX">CEI</a>) stock hit a yearly low of $1.78. The stock was down 4.25% for the day.</li>
<li>Biora Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIOR#NASDAQ">BIOR</a>) shares were down 4.27% for the day, having made a 52-week low of $2.21.</li>
</ul>
Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. <a href="https://pro.benzinga.com/?afmc=2a&amp;utm_source=benzinga.com&amp;utm_medium=web&amp;utm_campaign=premium_products">Click here to learn more</a>.

ALLO

AMTX

APPN

ASAN

ASPS

BBBY

BIOR

CELU

CRGE

CRGY

CRWD

DDOG

ESEA

FMBH

HYFM

IBTX

INVH

JAMF

LFCR

MPLN

MTBC

NVOS

ONDS

PANW

QBTS

RiverNorth Marketplace Lending Corporation Common Stock

SBNY

SEER

SLDP

TDOC

VERA

XERS

YELL

Stocks That Hit 52-Week Lows On Thursday

National Healthcare (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/NHC#AMEX">NHC</a>) reported quarterly earnings of $0.50 per share. This is a 47.92 percent decrease over earnings of $0.96 per share from the same period last year. The company reported $270.84 million in sales this quarter. This is a 2.13 percent decrease over sales of $276.74 million the same period last year.

National Healthcare Q3 EPS $0.50 Down From $0.96 YoY, Sales $270.84M Down From $276.74M YoY

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.nhccare.com&amp;esheet=52805901&amp;newsitemid=20220808005826&amp;lan=en-US&amp;anchor=National+HealthCare+Corporation&amp;index=1&amp;md5=b96d67df0dce73a70ab000e731b360a6">National HealthCare Corporation</a>&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NHC#NYSE">NHC</a>), announces that its Board of Directors, at a regularly scheduled meeting, has authorized a new stock repurchase program. The program will allow for repurchases of up to&nbsp;$25 million&nbsp;of its common stock. The new stock repurchase plan will begin August 11, 2022 and will expire on August 10, 2023. The stock repurchase plan replaces the stock repurchase plan previously approved by the Board of Directors on August 8, 2019, which expired on August 31, 2020.
Under the stock repurchase program, the Company may repurchase its common stock from time to time, in amounts and at prices the Company deems appropriate, subject to market conditions and other considerations. The Company&#39;s repurchases may be executed using open market purchases, privately negotiated agreements or other transactions. The Company intends to fund repurchases under the new stock repurchase program from cash on hand, available borrowings or proceeds from potential debt or other capital market sources. The stock repurchase program may be suspended or discontinued at any time without prior notice. The Company will provide an update regarding any purchases made pursuant to the stock repurchase program each time it reports its results of operations.

Buybacks

NHC Announces $25 Million Stock Repurchase Program

National Healthcare Q2 EPS $0.46 vs $0.98 YoY

<h3>What Defines a Value Stock?</h3>
A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be undervalued, as investors are not expressing as much interest in such companies. The most commonly used way to check for value is with the price-to-earnings multiple, or P/E. A low P/E multiple is a good indication that the stock is undervalued. 
<h2>Below is a list of notable value stocks in the healthcare sector:</h2>
<ol>
<li>Tilray (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) - P/E: 9.43</li>
<li>National Healthcare (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/NHC#AMEX">NHC</a>) - P/E: 8.11</li>
<li>Sensus Healthcare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRTS#NASDAQ">SRTS</a>) - P/E: 6.22</li>
<li>Achilles Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACHL#NASDAQ">ACHL</a>) - P/E: 0.45</li>
<li>Innoviva (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INVA#NASDAQ">INVA</a>) - P/E: 6.62</li>
</ol>
Tilray has been featured as a value stock. Tilray's Q3 EPS sits at $0.03, which has not changed since last quarter (Q2). Most recently, National Healthcare reported earnings per share at $0.91, whereas in Q4 earnings per share sat at $1.02. Most recently, the company reported a dividend yield of 3.23%, which has decreased by 0.18% from last quarter's yield of 3.41%.
Sensus Healthcare saw a decrease in earnings per share from 0.32 in Q4 to $0.2 now. Achilles Therapeutics looks to be undervalued. It possesses an EPS of $-0.45, which has not changed since last quarter (Q4). Most recently, Innoviva reported earnings per share at $0.39, whereas in Q4 earnings per share sat at $0.14. 
The Significance: A value stock may need some time to rebound from its undervalued position. The risk of investing in a value stock is that this emergence may never materialize.

ACHL

INVA

SRTS

TLRY

5 Value Stocks To Watch In The Healthcare Sector

Is the United States heading toward a recession?
This has been the looming question on the minds of Americans since inflation topped at 8.5% in March, matched with other indicators such as&nbsp;rising interest rates and the bond market&rsquo;s inverted yield curve.
Top economists are split on the inevitability of a recession.&nbsp;Former&nbsp;Goldman Sachs Group Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gs#NYSE">GS</a>)&nbsp;CEO Lloyd Blankfein <a href="https://www.youtube.com/watch?v=fDfsV9A4Q1M">said over the weekend</a>, &ldquo;It&rsquo;s certainly a very, very high-risk factor,&rdquo; but believes that the Fed is responding well to the risk.
Moody&rsquo;s Corporation&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mco#NYSE">MCO</a>) chief economist Mark Zandi <a href="https://fortune.com/2022/04/19/will-economy-enter-recession-odds-mark-zandi-biden/">predicted </a>a 35% probability that America will enter a recession in the next two years. Twitter Inc.&#39;s&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/twtr#NYSE">TWTR</a>)&nbsp;most-loved Elon Musk <a href="https://twitter.com/elonmusk/status/1476619907076923398?lang=en">predicted&nbsp;a recession</a> as early as the summer of 2022.
Conflicting outlooks aside, it is essential to look at the facts and what has historically preceded a recession.
The yield curve inverted on March 29 for the first time since 2019. This occurs when the short-term U.S. treasury is paying a higher interest rate than long-term U.S. treasuries. More than that, Fed Chair Jerome Powell indicated a 50 basis point increase, up from the traditional 0.25% at the last FOMC (Federal Open Market Committee) meeting.
The known definition of a recession is a period of temporary economic decline during which trade and industrial activity are reduced, generally identified by a fall in GDP in two successive quarters. <a href="https://www.bea.gov/news/2022/gross-domestic-product-first-quarter-2022-advance-estimate#:~:text=Real%20gross%20domestic%20product%20(GDP,real%20GDP%20increased%206.9%20percent.">According to the Bureau of Economic analysis</a>, the GDP decreased at an annual rate of 1.4%, down from 6.9% in the fourth quarter of 2021.
While the macro outlook is pessimistic at best, it is critical to understand the broader market trends that indicate where money moves, such as&nbsp;the economic cycle and sector rotation.
It is&nbsp;known that a recession is a natural part of a growing economy and&nbsp;as part of the economic cycle. The cycle can be simply defined as when the economy moves from a growth stage to a recession and back to growth. This is probably the most influential force on the broader markets because it directly relates to stock prices vis-a-vis company profits.
The stock market&#39;s relationship with the economic cycle lies in the various sectors that make up the markets, which are sensitive to different stages of the cycle.
Are you confused yet? This should make it easy.
Some sectors will outperform when the economy is growing (Industrials, Consumer names, Real Estate) and others when the economy is in a recession (Healthcare, Food, Consumer Staples, Utilities)
This is known as sector rotation or the way investors move money during the various stages of the economic cycle.
When the economy moves toward a recession, investors usually rotate into sectors that are less sensitive to the economic cycle, such as&nbsp;Consumer Staples and Utilities; these are known as defensive sectors because they can offer a relative level of protection during an economic downturn.
Some of those defensive names include:
Coca-Cola Co (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ko#NYSE">KO</a>) 
Albertsons Companies Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aci#NYSE">ACI</a>) 
Altria Group Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mo#NYSE">MO</a>) 
NRG Energy Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nrg#NYSE">NRG</a>) 
PG&amp;E Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pcg#NYSE">PCG</a>) 
Clearway Energy Inc&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cwen#NYSE">CWEN</a>) 
National HealthCare Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nhc#NYSE">NHC</a>) 
HealthStream, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hstm#NASDAQ">HSTM</a>) 
Regencell Bioscience Holdings Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rgc#NASDAQ">RGC</a>)
On the opposite end, when emerging from a recession, investors rotate into highly sensitive names to the cycle, such as&nbsp;Industrials and Consumer cyclicals.
Read also:&nbsp;<a href="http://NYSE Or NASDAQ? Here's Why Stocks Get Listed">NYSE Or NASDAQ? Here&#39;s Why Stocks Get Listed&nbsp;There</a>
Some of those names include:
Caterpillar Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cat#NYSE">CAT</a>) 
Johnson &amp; Johnson (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/jnj#NYSE">JNJ</a>) 
Ecolab Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ecl#NYSE">ECL</a>) 
Chevron Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cvx#NYSE">CVX</a>) 
Tesla Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tsla#NASDAQ">TSLA</a>) 
JPMorgan Chase &amp; Co. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/jpm#NYSE">JPM</a>) 
Boeing Co&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ba#NYSE">BA</a>) 
Mastercard Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ma#NYSE">MA</a>)

Entertainment

Education

General

CWEN

HSTM

TSLA

TWTR

Sector Rotation And 9 Stocks To Watch During A Recession

When we enter a period of economic uncertainty, the phrase &quot;recession-proof stocks&quot; is tossed about, but really the only certainty is that recession-proof stocks do not exist.
On the other hand, recession-resistant companies&nbsp;are what a savvy investor searches for during the absence of a bull market, as we are now.
Historically, cyclical sectors such as&nbsp;financial&nbsp;and consumer directories have outperformed during bull markets. These equities are frequently susceptible to interest rates and economic growth, so they perform worse than others during a bear market or imminent recession.
Consumer preferences shift from optional and luxury purchases to essential home products and services during a recession as individuals are more concerned with their bottom line.
During uncertain periods such as&nbsp;this, the smart money rotates into recession-resistant or defensive sectors like Consumer Staples, Utilities and Health Care, all of which historically perform well during a recession.
Energy (+49.17%) is the sector with the most significant returns this year, owing to rising oil prices, supply-chain concerns, and demand for gas, energy equipment, and services while the war in Ukraine continues.
This bear market is different. Year-to-date, the returns for the following sectors are: 
Consumer Staples: -0.62% 
Utilities: +0.73% 
Health Care: -8.1%
On the surface, these sectors could look like uncertain investments, bur peeking into them tells a different story and provides investment ideas.
Consumer Staples: 
Beverages: +2.21%
<ul>
<li>Coca-Cola Co (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ko#NYSE">KO</a>)</li>
<li>PepsiCo, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pep#NASDAQ">PEP</a>)</li>
<li>Constellation Brands, Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/stz#NYSE">STZ</a>)</li>
</ul>
Food Products: +8.76%
<ul>
<li>Albertsons Companies Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aci#NYSE">ACI</a>)</li>
<li>SpartanNash Co (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sptn#NASDAQ">SPTN</a>)</li>
<li>Andersons Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ande#NASDAQ">ANDE</a>)</li>
</ul>
Tobacco: +9.27
<ul>
<li>Altria Group Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mo#NYSE">MO</a>)</li>
<li>British American Tobacco PLC (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bti#NYSE">BTI</a>)</li>
<li>Vector Group Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vgr#NYSE">VGR</a>)</li>
</ul>
Utilities: 
Electric Utilities: -1.71%
<ul>
<li>NRG Energy Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nrg#NYSE">NRG</a>)</li>
<li>DTE Energy Co (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dte#NYSE">DTE</a>)</li>
<li>OGE Energy Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/oge#NYSE">OGE</a>)</li>
</ul>
Multi-Utilities: +9.05%
<ul>
<li>PG&amp;E Corporation&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pcg#NYSE">PCG</a>)</li>
<li>Black Hills&nbsp;Corp (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bkh#NYSE">BKH</a>)</li>
<li>Exelon Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/exc#NASDAQ">EXC</a>)</li>
</ul>
Independent Power and Renewable Energy: -13.83%
<ul>
<li>Clearway Energy Inc Class A (NYSE:<a href="https://www.google.com/finance/quote/CWEN.A:NYSE"> CWEN.A</a>)</li>
<li>NextEra Energy Inc&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nee#NYSE">NEE</a>)</li>
<li>First Solar, Inc.&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fslr#NASDAQ">FSLR</a>)</li>
</ul>
Health Care: 
Providers &amp; Services: +1.23%
<ul>
<li>National HealthCare Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nhc#NYSE">NHC</a>)</li>
<li>Davita Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dva#NYSE">DVA</a>)</li>
<li>Alignment Healthcare Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alhc#NASDAQ">ALHC</a>)</li>
</ul>
Health Care Tech: +1.22%
<ul>
<li>Sophia Genetics SA (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/soph#NASDAQ">SOPH</a>)</li>
<li>Computer Programs &amp; Systems, Inc.&nbsp;(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cpsi#NASDAQ">CPSI</a>)</li>
<li>HealthStream, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hstm#NASDAQ">HSTM</a>)</li>
</ul>
Pharmaceuticals: -0.55%
<ul>
<li>Viatris Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vtrs#NASDAQ">VTRS</a>)</li>
<li>Regencell Bioscience Holdings Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rgc#NASDAQ">RGC</a>)</li>
<li>Prestige Consumer Healthcare Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pbh#NYSE">PBH</a>)</li>
</ul>
Photo:&nbsp;<a href="https://pixabay.com/users/theinvestorpost-19152356/?utm_source=link-attribution&amp;utm_medium=referral&amp;utm_campaign=image&amp;utm_content=5771541">TheInvestorPost</a>&nbsp;from&nbsp;Pixabay&nbsp;

ALHC

ANDE

CPSI

FSLR

SOPH

SPTN

VTRS

27 Recession-Resistant Stocks To Look At Now

National Healthcare (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/NHC#AMEX">NHC</a>) reported quarterly earnings of $0.91 per share. This is a 15.74 percent decrease over earnings of $1.08 per share from the same period last year. The company reported $278.98 million in sales this quarter. This is a 11.16 percent increase over sales of $250.97 million the same period last year.

National Healthcare Q1 Adj. EPS $0.91 Down From $1.08 YoY, Sales $278.98M Up From $250.97M YoY

Dividends

NHC Raises Quarterly Dividend From $0.55 To $0.57/Share

<h3>The Meaning Behind Value Stocks</h3>
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock. 
<h2>Benzinga Insights has compiled a list of value stocks in the healthcare sector that may be worth watching:</h2>
<ol>
<li>Retractable Technologies (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/RVP#AMEX">RVP</a>) - P/E: 3.36</li>
<li>National Healthcare (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/NHC#AMEX">NHC</a>) - P/E: 8.03</li>
<li>Cross Country Healthcare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CCRN#NASDAQ">CCRN</a>) - P/E: 6.38</li>
<li>Walgreens Boots Alliance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBA#NASDAQ">WBA</a>) - P/E: 6.41</li>
<li>Metacrine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTCR#NASDAQ">MTCR</a>) - P/E: 0.56</li>
</ol>
This quarter, Retractable Technologies experienced an increase in earnings per share, which was $0.19 in Q3 and is now $0.61. Most recently, the company reported a dividend yield of 13.16%, which has decreased by 0.1% from last quarter's yield of 13.26%.
National Healthcare saw an increase in earnings per share from 0.96 in Q3 to $1.02 now. Its most recent dividend yield is at 3.41%, which has increased by 0.36% from 3.05% in the previous quarter.
This quarter, Cross Country Healthcare experienced an increase in earnings per share, which was $0.61 in Q3 and is now $1.4. This quarter, Walgreens Boots Alliance experienced a decrease in earnings per share, which was $1.68 in Q1 and is now $1.59. Its most recent dividend yield is at 3.84%, which has decreased by 0.14% from 3.98% in the previous quarter.
Most recently, Metacrine reported earnings per share at $-0.44, whereas in Q3 earnings per share sat at $-0.69. 
These 5 value stocks were selected by Benzinga Insights based on quantified analysis. While this methodical judgment process is not meant to make final decisions, our technology can give investors additional perception into the sector.